Teva Pharmaceuticals teams with The Anderson Group

02/20/2007

Teva Pharmaceuticals, the leading generic pharmaceutical company, has enlisted The Anderson Group to re-launch TEVA Clozapine, a drug used for the treatment of severe schizophrenia. The Anderson Group will be working on materials aimed at physicians, pharmacists, caregivers and patients. Teva USA, headquartered in Horsham, PA, is a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd., Israel�s largest pharmaceutical manufacturer operating globally in 19 countries on five continents.